We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Ivermectin

News List

Bangladesh launches clinical trial of two-drug combination to treat COVID-19 expresspharma
June 19, 2020
Reportedly, the combination of anti-parasitic medicine Ivermectin and antibiotic doxycycline cured all the 60 COVID-19 patients within days.
Study finds anti-parasitic drug could kill coronavirus in 48 hours pharmaceutical-technology
April 07, 2020
Researchers from Biomedicine Discovery Institute (BDI) at Monash University in Australia have found that an anti-parasitic drug called Ivermectin could kill the novel coronavirus, SARS-CoV-2, within 48 hours in a laboratory setting.
The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro sciencedirect
April 07, 2020
Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 hours post infection with SARS-CoV-2 able to
Ivermectin found to suppresses tumour development europeanpharmaceuticalreview
September 29, 2017
Researchers find ivermectin, a drug used to kill parasites, suppresses tumour development in epithelial ovarian cancer…

Previous page 1 2 Next page